IC
MGNX icon

Ikarian Capital’s MacroGenics MGNX Stock Holding History

Ikarian Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-523,500
Closed -$7.71M – 145
2024
Q1 		$7.71M Buy
+523,500
New +$7.91M 0.84% 39
2021
Q4 		– Sell
-446,000
Closed -$9.34M – 220
2021
Q3 		$9.34M Buy
446,000
+146,000
+49% +$3.52M 0.66% 42
2021
Q2 		$8.06M Buy
300,000
+100,000
+50% +$2.93M 0.65% 44
2021
Q1 		$6.37M Buy
+200,000
New +$4.86M 0.21% 104
2020
Q1 		– Sell
-150,000
Closed -$1.63M – 167
2019
Q4 		$1.63M Buy
+150,000
New +$1.48M 0.26% 66

Other funds holding MGNX

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Ikarian Capital's MGNX Position: Q2 2026 in Review

Ikarian Capital held its MacroGenics (MGNX) position steady in Q2 2026 at 74,893 shares worth $346K. The position accounts for 0.04% of the portfolio, ranked #133.

Ikarian Capital first reported a position in MGNX in Q4 2019 and has held it in 18 quarters since. The position peaked at $15.9M in Q1 2021. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Ikarian Capital held 74,893 shares of MacroGenics worth $346K as of Q2 2026.
  • Ikarian Capital left its MacroGenics share count unchanged in Q2 2026.
  • MacroGenics made up 0.04% of Ikarian Capital's portfolio in Q2 2026, its #133 holding.
  • Ikarian Capital first reported a position in MacroGenics in Q4 2019 and has held it in 18 quarters since.
  • Ikarian Capital's MacroGenics position peaked at $15.9M in Q1 2021.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.